Compare PCVX & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | MKSI |
|---|---|---|
| Founded | 2013 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 11.0B |
| IPO Year | 2020 | 1999 |
| Metric | PCVX | MKSI |
|---|---|---|
| Price | $47.81 | $162.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | $101.67 | ★ $154.60 |
| AVG Volume (30 Days) | ★ 1.5M | 896.8K |
| Earning Date | 11-04-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | N/A | ★ 820.97 |
| EPS | N/A | ★ 4.12 |
| Revenue | N/A | ★ $3,832,000,000.00 |
| Revenue This Year | N/A | $10.71 |
| Revenue Next Year | N/A | $7.30 |
| P/E Ratio | ★ N/A | $39.34 |
| Revenue Growth | N/A | ★ 8.13 |
| 52 Week Low | $27.66 | $54.84 |
| 52 Week High | $93.77 | $170.37 |
| Indicator | PCVX | MKSI |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 57.95 |
| Support Level | $42.40 | $146.90 |
| Resistance Level | $48.65 | $160.78 |
| Average True Range (ATR) | 1.75 | 5.45 |
| MACD | 0.16 | -0.64 |
| Stochastic Oscillator | 92.34 | 71.45 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.